These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 29511142)
1. Animal models for the study of hepatitis B virus infection. Guo WN; Zhu B; Ai L; Yang DL; Wang BJ Zool Res; 2018 Jan; 39(1):25-31. PubMed ID: 29511142 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck. Kosinska AD; Liu J; Lu M; Roggendorf M Med Microbiol Immunol; 2015 Feb; 204(1):103-14. PubMed ID: 25535101 [TBL] [Abstract][Full Text] [Related]
3. Activity of nucleic acid polymers in rodent models of HBV infection. Schöneweis K; Motter N; Roppert PL; Lu M; Wang B; Roehl I; Glebe D; Yang D; Morrey JD; Roggendorf M; Vaillant A Antiviral Res; 2018 Jan; 149():26-33. PubMed ID: 29126900 [TBL] [Abstract][Full Text] [Related]
4. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation. Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488 [TBL] [Abstract][Full Text] [Related]
5. Animal Models of Hepatitis B Virus Infection-Success, Challenges, and Future Directions. Liu Y; Maya S; Ploss A Viruses; 2021 Apr; 13(5):. PubMed ID: 33924793 [TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans. Korba BE; Cote P; Hornbuckle W; Tennant BC; Gerin JL Hepatology; 2000 May; 31(5):1165-75. PubMed ID: 10796894 [TBL] [Abstract][Full Text] [Related]
7. Transgenic mice as a chemotherapeutic model for hepatitis B virus infection. Morrey JD; Korba BE; Sidwell RW Antivir Ther; 1998; 3(Suppl 3):59-68. PubMed ID: 10726056 [TBL] [Abstract][Full Text] [Related]
8. Animal models for the study of human hepatitis B and D virus infection: New insights and progress. Burwitz BJ; Zhou Z; Li W Antiviral Res; 2020 Oct; 182():104898. PubMed ID: 32758525 [TBL] [Abstract][Full Text] [Related]
9. Recent Drug Development in the Woodchuck Model of Chronic Hepatitis B. Suresh M; Menne S Viruses; 2022 Aug; 14(8):. PubMed ID: 36016334 [TBL] [Abstract][Full Text] [Related]
10. The woodchuck: a model for therapeutic vaccination against hepadnaviral infection. Roggendorf M; Yang D; Lu M Pathol Biol (Paris); 2010 Aug; 58(4):308-14. PubMed ID: 20646874 [TBL] [Abstract][Full Text] [Related]
11. Low hepatitis B virus-specific T-cell response in males correlates with high regulatory T-cell numbers in murine models. Kosinska AD; Pishraft-Sabet L; Wu W; Fang Z; Lenart M; Chen J; Dietze KK; Wang C; Kemper T; Lin Y; Yeh SH; Liu J; Dittmer U; Yuan Z; Roggendorf M; Lu M Hepatology; 2017 Jul; 66(1):69-83. PubMed ID: 28295453 [TBL] [Abstract][Full Text] [Related]
12. Mouse models of hepatitis B and delta virus infection. Dandri M; Lütgehetmann M J Immunol Methods; 2014 Aug; 410():39-49. PubMed ID: 24631647 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model. Roggendorf M; Schulte I; Xu Y; Lu M J Viral Hepat; 2007 Nov; 14 Suppl 1():51-7. PubMed ID: 17958643 [TBL] [Abstract][Full Text] [Related]
14. Interferon-β response is impaired by hepatitis B virus infection in Tupaia belangeri. Kayesh MEH; Ezzikouri S; Chi H; Sanada T; Yamamoto N; Kitab B; Haraguchi T; Matsuyama R; Nkogue CN; Hatai H; Miyoshi N; Murakami S; Tanaka Y; Takano JI; Shiogama Y; Yasutomi Y; Kohara M; Tsukiyama-Kohara K Virus Res; 2017 Jun; 237():47-57. PubMed ID: 28551415 [TBL] [Abstract][Full Text] [Related]
15. Establishing a new animal model for hepadnaviral infection: susceptibility of Chinese Marmota-species to woodchuck hepatitis virus infection. Wang BJ; Tian YJ; Meng ZJ; Jiang M; Wei BQ; Tao YQ; Fan W; Li AY; Bao JJ; Li XY; Zhang ZM; Wang ZD; Wang H; Roggendorf M; Lu MJ; Yang DL J Gen Virol; 2011 Mar; 92(Pt 3):681-91. PubMed ID: 21084496 [TBL] [Abstract][Full Text] [Related]
16. The role of the woodchuck model in the treatment of hepatitis B virus infection. Kulkarni K; Jacobson IM; Tennant BC Clin Liver Dis; 2007 Nov; 11(4):707-25, vii. PubMed ID: 17981226 [TBL] [Abstract][Full Text] [Related]
17. Animal models of HBV infection. Dandri M; Petersen J Best Pract Res Clin Gastroenterol; 2017 Jun; 31(3):273-279. PubMed ID: 28774409 [TBL] [Abstract][Full Text] [Related]
18. Experimental in vitro and in vivo models for the study of human hepatitis B virus infection. Allweiss L; Dandri M J Hepatol; 2016 Apr; 64(1 Suppl):S17-S31. PubMed ID: 27084033 [TBL] [Abstract][Full Text] [Related]
19. Mouse Models of Hepatitis B Virus Pathogenesis. Iannacone M; Guidotti LG Cold Spring Harb Perspect Med; 2015 Aug; 5(11):. PubMed ID: 26292984 [TBL] [Abstract][Full Text] [Related]
20. Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes. Tabuchi A; Tanaka J; Katayama K; Mizui M; Matsukura H; Yugi H; Shimada T; Miyakawa Y; Yoshizawa H J Med Virol; 2008 Dec; 80(12):2064-8. PubMed ID: 19040280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]